Bolt Biotherapeutics(BOLT) - 2024 Q4 - Annual Results

Exhibit 99.1 Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update REDWOOD CITY, CA, Mar. 24, 2025 – Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today reported financial results for the third quarter ended December 31, 2024, and provided a business update. "2024 was a transformational year for Bolt as we focused the company on efficient development of the ...